Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Research News
In late January, the biotech firm Myriad Genetics put out a press release announcing the discovery of a new tumor suppressor. The company took the step to forestall possible charges of insider trading by company employees, but it also had another effect: triggering an intense effort by a competing group to get its own discovery of the gene into print.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)